- Global Pharma News & Resources

Press Releases - 2019-11-04

Date Title Company
04-Nov-2019 Luminex Corporation Reports Third Quarter 2019 Results and Submission of VERIGENE II Gastrointestinal Flex Assay to the FDA Luminex Corporation
04-Nov-2019 Epigenomics AG: No operational reasons for sharp decline in share price Epigenomics AG
04-Nov-2019 MiLaboratories' MiXCR Immune Repertoire Analyzer version 2.1.11 is now available at Illumina BaseSpace(TM) MiLaboratories LLC
04-Nov-2019 GetInsured Successfully Upgrades Technology for Minnesota's Health Insurance Exchange GetInsured
04-Nov-2019 Royal College of Occupational Therapists launch ‘Small Change, Big Impact’ campaign Royal College of Occupational Therapists
04-Nov-2019 Exclusive interview from conference speaker John Lisman released ahead of Parallel Trade 2020 SMi Group
04-Nov-2019 Hardy Diagnostics Presents the New Generation of Active Microbial Air Samplers Hardy Diagnostics
04-Nov-2019 Positive results in Phase 3 trial for Toujeo® in children and adolescents with type 1 diabetes Sanofi
04-Nov-2019 Olympus SLIDEVIEW VS200 Solution with Reliable, Flexible, and High-Throughput Slide Scanning Olympus
04-Nov-2019 Exclusive interview from conference speaker Torsten Kneuss released ahead of SMi’s Pre-Filled Syringes 2020 Conference SMi Group
04-Nov-2019 Independent SMO Panthera Biopartners launches with its first clinical trial site in the UK Panthera Biopartners
04-Nov-2019 Vifor Pharma enters into commercial collaboration in the US with Janssen Vifor Pharma Group
04-Nov-2019 RedHill Biopharma Announces FDA Approval of Talicia® for Treatment of H. pylori in Adults RedHill Biopharma Ltd
04-Nov-2019 Ichnos Sciences Announces Completion of Enrollment of Phase 2b Trials for Two Investigational Therapies - ISB 830 And ISC 27864 B3C newswire
04-Nov-2019 Joining Forces – OPEN Health and Pharmerit International Merger OPEN Health
04-Nov-2019 European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Adult Patients with Advanced Renal Cell Carcinoma (RCC) Merck
04-Nov-2019 emotive adds new company value to embrace the varied working landscape of med comms emotive
04-Nov-2019 emotive welcomes four new team members emotive
04-Nov-2019 Immunoprecipitation Market Worth $910.0 Million By 2026 | CAGR: 5.3%: Grand View Research, Inc. Grand View Research, Inc.
04-Nov-2019 emotive develops new branding for Medics4RareDiseases emotive